Prof Chris Mason, MD, PhD, FRCS, FMedSci.

Co-Founder and Non-Executive Director

Chris is a clinician-scientist with over 25 years of CGT experience. He is a Founder and CSO of AVROBIO (NASDAQ: AVRO) and Professor of Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London.